Editor’s Note: This publication originally appeared on LHC Group’s website.
LAFAYETTE, La. (December 5, 2019) – Lafayette-based LHC Group has announced that Dr. Benjamin Doga – previously part-time chief medical officer – has transitioned into a new role as the company’s senior medical advisor.
Dr. Doga is a longtime member of the local and regional medical community and continues to maintain a general and family medicine practice in Lafayette. He joined LHC Group in 2014 and served in a part-time capacity until the company hired a full-time CMO in July.
In this new capacity, Dr. Doga will advise the chairman and CEO, the board of directors, and the board’s quality committee – in conjunction with the full-time CMO, Dr. Tricia Nguyen – on all medical aspects of clinical delivery models and programs.
In addition to these responsibilities, Dr. Doga will also:
- serve as lead medical director overseeing all local agency medical directors
- serve as a permanent member of the company’s internal quality committee
- participate in internal operations meetings, compliance meetings, clinical workgroups, and committees, etc., as requested by the chairman and CEO, chief compliance officer, chief clinical officer, or general counse
- advise the board and management team in areas of risk
News from our Partner
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
